Specific Clinical Experience Investigation for long-term use of exenatide (Byetta subcutaneous injection)

Study identifier:D5550C00001

ClinicalTrials.gov identifier:NCT01817569

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Specific Clinical Experience Investigation for long-term use of exenatide (Byetta subcutaneous injection)

Medical condition

Type 2 Diabetes

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

2948

Study type

Observational

Age

N/A

Date

Study Start Date: 13 Feb 2011
Primary Completion Date: 03 Oct 2019
Study Completion Date: 03 Oct 2019

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2020 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria